By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Pepiniere Sante Cochin
29 rue du Faubourg Saint Jacques
Paris    75014  France
Phone: 01-55-426200 Fax: 01-55-426201


Company News
PHARNEXT Announces Strategic Partnership With Tasly Pharmaceutical, A Leading Chinese Pharmaceutical Group 5/10/2017 6:46:50 AM
PHARNEXT Reports Year End 2016 Financial Results 4/26/2017 11:28:44 AM
PHARNEXT Announces Reclassification Of Its Historical Investor’s Shares, Strengthening The Position Of Core Shareholders 3/29/2017 10:34:27 AM
PHARNEXT To Present New PXT864 Synergy Data At AD/PDTM 2017, The 13th International Conference On Alzheimer's And Parkinson's Diseases And Related Neurological Disorders 3/29/2017 7:22:30 AM
PHARNEXT Announces Initiation Of Phase III Extension Study PLEO-CMT-FU Of PXT3003 For Treatment Of Charcot-Marie-Tooth Disease Type 1A 3/16/2017 11:06:12 AM
PHARNEXT Announces R&D Agreement With Galapagos (GLPG.BR) To Generate A New Pipeline Of Synergistic Drug Combinations 3/9/2017 10:03:06 AM
PHARNEXT To Present At 2017 BIO CEO & Investor Conference 2/7/2017 7:13:38 AM
PHARNEXT Announces Findings Evaluating Charcot-Marie-Tooth Neuropathy Score 2/2/2017 6:29:56 AM
PHARNEXT To Attend January Investor Conferences 1/4/2017 8:46:32 AM
PHARNEXT Completes Patient Enrollment In International Pivotal Phase 3 Trial Of PXT3003 For Charcot-Marie-Tooth Disease Type 1A 12/20/2016 12:58:14 PM